Incidence Of Allergic Diseases Research Articles

МНОГОЛЕТНИЕ ЭПИДЕМИОЛОГИЧЕСКИЕ ТРЕНДЫ ДИНАМИКИ АЛЛЕРГИЧЕСКОГО РИНИТА И АТОПИЧЕСКОГО ДЕРМАТИТА У ДЕТЕЙ

Background. Allergic rhinitis and atopic dermatitis are common allergic diseases in children. Analysis of the incidence and trends of allergic diseases development is necessary for successful solving the problem of morbidity, helping the child population at the regional level, disease forecasting and control. Purpose of the study. To study the long-term dynamics of the main epidemiological indicators of the general and primary incidence of allergic rhinitis and atopic dermatitis in the child population of the Grodno region. Material and methods. Retrospective analysis of indicators of general and primary incidence of allergic rhinitis and atopic dermatitis in the child population of the Grodno region was performed. The study periods were 1999-2023 years (children aged 0-14 years old) and 2008-2023 years (children aged 15-17 years old). Results. The average long-term age-standardized overall morbidity rate of allergic rhinitis in children aged 0-14 years old was 266.89 (95% CI: 238.33-295.47), the primary morbidity rate was 67.67 (95% CI: 57.36-77.9) per 100,000 children of the corresponding age. The average long-term overall incidence rate of allergic rhinitis in children aged 15-17 years (2008-2023) was 791.97 (95% CI: 680.79-903.14), the primary incidence rate was 113.73 (95% CI: 92.84- 134.61) per 100,000 children of the same age. The average long-term age-standardized rate of overall incidence of atopic dermatitis in children aged 0-14 years old was 872.89 (95% CI: 825.27-919.782) per 100,000 children of the corresponding age, the primary incidence rate was 459.1 (95% CI: 399. 96-518.24) per 100,000 children of the same age. The average long-term overall incidence rate of atopic dermatitis in children aged 15-17 years was 415.68 (95% CI: 377.63-453.73), the primary incidence rate was 143.88 (95% CI: 120.53-167.23) per 100,000 child population of the corresponding age. The long-term epidemic dynamics of allergic rhinitis was characterized by a moderately pronounced tendency towards an increase in the overall incidence rate among children aged 0-14 years old (average growth (decrease) rate = +2.4%) and 15-17 years old (average growth (decrease) rate = +3.62 %) as well as stabilization of the primary morbidity rate in children aged 0-14 years old (average growth (decrease) rate = -0.67%) and 15-17 years old (average growth (decrease) rate = +0.72%). The long-term epidemic dynamics of atopic dermatitis was characterized by a moderately pronounced tendency towards a decrease in the overall morbidity rate for children aged 0-14 years old (average growth (decrease) rate = -1.57%) and an increase in the morbidity rate for children of 15-17 years old (average growth (decrease) rate = +2.1%). There also was a pronounced downward trend in the primary morbidity rate of children aged 0-14 years old (average growth (decrease) rate = -5.42%) and children aged 15-17 years old (average growth (decrease) rate = -5.89%). The cartograms of the territorial distribution of incidence rates of allergic rhinitis and atopic dermatitis in the child population of the Grodno region in the periods 1999-2023 (0-14 years old) and 2008-2023 (15-17 years old) are presented. Conclusions. The reasons for the established patterns of changes in the incidence of allergic diseases in children of different age groups, as well as those living in different territories, are most likely due to the influence of environmental and socio-economic factors. The presented cartograms make it possible to visualize the incidence rates of allergic rhinitis and atopic dermatitis in individual territorial and administrative regions of the region.

Allergens weaning: what is missing from commercial baby food?

Background. Current recommendations for infant weaning suggest introducing common food allergens by the age of 12 months. While homemade meals are advisable, there is a notable demand for commercially available complementary foods (CACF). Furthermore, emerging evidence suggests a potential link between the consumption of ultra-processed products and the incidence of allergic diseases. This study aimed to examine the presence of the fourteen main food allergens in CACF ingredients through label analysis and evaluate their extent of processing. Methods. Between January and February 2024, labels of all CACF found in infant feeding sections of 10 Portuguese grocery retailers were analyzed. CACF were categorized based on the NOVA food classification system's processing levels. Milk formulas, products for children over 15 months, and those for children with food allergies or intolerances were excluded Results. Of the 492 products analysed, 132 contained wheat and 112 contained milk. 16 products included fish and 6 contained egg. Soy was listed as an ingredient in 11 products, mainly as soy lecithin. Only 2 product contained nuts, and 1 product contained peanuts. None of the products contained the remaining six allergens. The majority of milk- and wheat-containing products were classified as ultra-processed and contained added sugars and/or sweeteners. Conclusions. Despite the current guidelines, commercial baby foods often lack major allergens, namely nuts and peanuts, eggs, and shellfish. Our results underscore the need for healthy, age-appropriate, minimally processed products that incorporate rather than exclude major food allergens.

Dietary human milk oligosaccharides reduce allergic airway inflammation by modulating SCFAs level and ILC2 activity.

Group 2 innate lymphoid cells (ILC2s) play a crucial role in the progression of asthma, yet the regulatory mechanisms modulating ILC2 responses in asthma remain underexplored. Human milk oligosaccharides (HMOs), vital non-nutritive components of breast milk, are known to significantly shape immune system development and influence the incidence of allergic diseases. However, their impact on ILC2-driven asthma is not fully understood. Our research reveals that dietary HMOs act as potent inhibitors of ILC2 responses and allergic airway inflammation. Treatment with 2'-fucosyllactose (2'-FL) and 6'-sialyllactose (6'-SL) significantly reduced ILC2-related airway inflammation induced by papain or Alternaria alternata in mice, evidenced by decreased eosinophil (EOS) infiltration and lower IL-5 and IL-13 levels in BALF. Notably, while ILC2 expresses HMO receptors, HMO did not act directly on ILC2 but potentially modulated their activity through alterations in gut microbiota derived SCFAs. HMO treatments alleviated airway inflammation in SCFA-dependent manners, with SCFA depletion or receptor blocking reversing these beneficial effects. This study reveals the potential of dietary HMOs in managing asthma through modulation of ILC2 activity and the gut-lung axis, proposing a new therapeutic avenue that utilises the immunomodulatory capacities of nutritional components to combat respiratory diseases.

Six-year trend of subsequent allergic diseases following Kawasaki disease and its clinical implications: A population-based matched cohort study of 34,712 patients.

It has been suggested that allergic diseases may increase after Kawasaki disease (KD). We aimed to analyze the temporal patterns of allergic disease incidence after KD. A nationwide population-based matched cohort study was conducted using data from the Korean National Health Insurance claims database. Patients aged <5 years diagnosed with KD and their 1:3 propensity score-matched controls were included. Three cohorts were established: Cohort A, patients with allergies; Cohort B, patients without allergies; and Cohort C, patients without allergies, but excluding patients with birth history and underlying medical conditions. Cumulative incidence rates (%) and associated hospital visits for allergic rhinitis, atopic dermatitis, urticaria, and asthma were compared between the cases and controls during the 6-year follow-up period. The study population comprised 8678 patients diagnosed with KD and 26,034 controls. In Cohort A, although initially, there were intergroup differences in the number of hospital visits for certain allergic diseases, these differences were inconsistent and varied depending on the type of allergic disease. Over time, the differences narrowed, and by the sixth year, the gap had decreased significantly. In Cohorts B and C, the initial incidence rates of the four allergic diseases and associated hospital visits were lower in patients with KD as compared to controls. However, with a faster rate of increase, the incidence rates and number of hospital visits eventually surpassed those of the controls. The pattern of delayed increase in cumulative incidence rates and hospital visits for allergic diseases after KD suggests the possibility of a shared genetic or immunologic susceptibility between KD and allergic diseases, which becomes evident over time, rather than a direct influence of KD resulting in allergic diseases.

Decreased Treg cells induced by bisphenol A is associated with up-regulation of PI3K/Akt/mTOR signaling pathway and Foxp3 DNA methylation in spleen of adolescent mice

The current study aimed to explore whether bisphenol A (BPA) exposure aggravated the decrease in Tregs induced by ovalbumin (OVA) in adolescent female mouse models of asthma, and whether the process was associated with mTOR-mediated signaling pathways and DNA methylation levels. A total of 40 female C57BL/6 mice at the age of four weeks were used and divided into five groups after 1 week of domestication. Each group consisted of eight mice: the control group, OVA group, OVA + BPA (0.1 μg mL−1) group, OVA + BPA (0.2 μg mL−1) group, and OVA + BPA (0.4 μg mL−1) group. Results revealed that Foxp3 protein levels decreased in the spleens of mice exposed to BPA compared to those in the OVA group. After an elevation in BPA dose, the mRNAs of methyltransferases (Dnmt1, Dnmt3a, and Dnmt3b) were gradually upregulated. The mechanism was related to the activity of TLR4/NF-κB and PI3K/Akt/mTOR signaling pathways and the enhancement of Foxp3 DNA methylation. Our results, collectively, provided a new view for studying the mechanisms underlying BPA exposure-induced immune dysfunction. Investigation of the regulatory mechanisms of DNA methylation in the abnormal Th immune response caused by BPA exposure could help reveal the causes and molecular mechanisms underlying the high incidence of allergic diseases in children in recent years.

Analysis of Preventive Measures Based on Current Research Status of Allergic Reactions

Allergic reaction is also known as hypersensitivity reaction, refers to the abnormal specific immune response that occurs in the body after the sensitized body is exposed to the same antigen again. Allergic reaction is mainly physiological dysfunction or pathological damage to tissues and cells. In recent years, with the rapid changes in the human living environment, the incidence of allergic diseases has increased day by day. In the past 20 years, the incidence of allergic diseases has doubled in Western developed countries, and the global prevalence has reached as high as 22%. In recent years, many breakthroughs have been made in the diagnosis, prevention, and treatment of allergic diseases. But there are still gaps in many areas. This article analyzes the integration and analysis of allergy types, causes, treatments, and clinical symptoms. It provides basic knowledge and theoretical support for future research. The problem of preventing allergies has not yet been solved, and future research can focus on methods to prevent allergic diseases.

Cutaneous mastocytosis and allergic diseases in children: A cross-sectional study

BACKGROUND: Mastocytosis is a heterogeneous group of diseases characterized by abnormal accumulation of clonal mast cells in one or more organs. Comorbidities in patients with mastocytosis include IgE-dependent allergies, psychiatric or psychological disorders, and vitamin D deficiency. Despite the clinical similarities between allergies and mastocytosis, only a few European studies have considered these comorbidities.&#x0D; AIM: To analyze the frequency of concomitant-allergic diseases in children with cutaneous mastocytosis.&#x0D; MATERIALS AND METHODS: Data of 248 children aged 6 months to 17 years who were diagnosed with cutaneous mastocytosis and received outpatient treatment and observation at the Moscow Scientific and Practical Center for Dermatovenereology and Cosmetology between March 2022 and June 2023 were analyzed. Serum levels of total and allergen-specific IgE were analyzed in children with and without allergic diseases. In addition, a positive history of allergy was analyzed in close relatives of children with cutaneous mastocytosis.&#x0D; RESULTS: Every third child (36.7%) with cutaneous mastocytosis had a concomitant allergic disease. Relatives of 27.4% of the examined children had allergic diseases. The process was significantly more often accompanied by allergic diseases in children with mastocytomas than in those with maculopapular cutaneous mastocytosis (χ2=45.46; p=0.001). The level of total IgE was not a statistically significant sign of the presence of allergic diseases in cutaneous mastocytosis (χ2=1.161; p=0.3). Allergen-specific IgE was detected in 47.2% of the children with allergic diseases. Among children without signs of food allergy and pollinosis, asymptomatic low and moderate sensitization to any plant product and birch was detected in 26.5%. Sensitization to respiratory allergens was found in 8% of children with cutaneous mastocytosis without allergic diseases.&#x0D; CONCLUSIONS: In Russia, this study demonstrated for the first time a high incidence of allergic diseases in children with cutaneous mastocytosis. The results showed that all clinical forms of mastocytosis in children, including cutaneous mastocytosis, should be subjected to interdisciplinary observation and examination. The timely detection of comorbid allergic diseases contributes to the development of individual techniques for the treatment and prevention of complications and anaphylaxis.

Associations between diet diversity during infancy and atopic disease in later life: Systematic review

The incidence of allergic disease remains high, and many studies have focused on the association between food diversity in infancy and allergic disease later in life, but their conclusions are still controversial. We aimed to synthesize the literature on the association between childhood diet diversity and atopic disease. We searched the PubMed, Cochrane Library, Embase, Scopus, VPCS, and Wanfang databases for studies about food diversity and atopic disease. Seventeen high-quality studies, 14 cohort studies, and 1 case-control study were included from 5244 studies with sample sizes ranging from 100 to 5225. All high-quality cohort studies showed that increasing food diversity in infancy can effectively prevent the occurrence of food allergies (5/5). Moderate evidence showed that increased food diversity reduced the risk of asthma (4/6), food sensitization (3/5), and atopic dermatitis (3/5). However, its effect on eczema (5), allergic rhinitis (4), and other diseases remains controversial. Increasing food diversity during infancy is a potential method for preventing food allergy, asthma, atopic dermatitis, and food sensitization later in life. There is little or no comparative evidence about the protective effect of food diversity on other atopic diseases.

Allergen Sensitization and Its Association With Allergic Diseases in the Korean Population: Results From the 2019 Korea National Health and Nutrition Examination Survey.

Allergen exposure is the most potent factor in allergen sensitization, which affects the exacerbation and severity of allergic diseases. Due to industrialization and climate change, the pattern of allergen sensitization has changed over time, and the incidence of allergic diseases has also increased. This study investigated the status of allergen sensitization in the Korean population and its effects on allergic diseases. A total of 2,386 participants aged ≥ 10 years, who underwent 7 specific immunoglobulin E tests for aeroallergens (Dermatophagoides farinae [Der f], dog dander, cat epithelium, birch, oak, Japanese hop, and ragweed), were selected among the participants of the 2019 Korean National Health and Nutrition Examination Survey. We compared the demographic characteristics, combined allergic diseases, and sinusitis symptoms between the atopic and non-atopic groups. The prevalence of allergen sensitization in the general Korean population was 45%, and Der f was the most frequent cause of sensitization (39.9%). The prevalence of sensitization to indoor allergens was highest among teenagers and those belonging to the 20- to 29-year age group (P < 0.001). In contrast, there was a high prevalence of sensitization to outdoor allergens among individuals belonging to the age group of 60-69 years. The prevalence of atopic dermatitis (odds ratio [OR], 2.559; 95% confidence interval [CI], 1.689-3.878), allergic rhinitis (OR, 3.075; 95% CI, 2.426-3.897), and otitis media (OR, 1.481; 95% CI, 1.092-2.007) significantly increased by allergen sensitization. Patients with allergen sensitization were more likely to experience the symptoms of rhinitis and sinusitis. The study findings confirmed that allergen sensitization occurs in approximately half of the general Korean population and affects the prevalence and symptoms of allergic diseases. This suggests that active allergy tests and diagnosis of allergic diseases are necessary in Koreans.

Klimatske promene i zdravlje ljudi

Compared to the end of the 19th century, the average temperature of the earth's surface is higher by 1.1o C, and the last decade (2011-2020) was the warmest recorded since 1850. Mortality rate to high temperatures increases by 1-4% for each degree of increase in air temperature due to dehydration, heatstroke, and worsening of existing respiratory and cardiovascular diseases. Natural disasters such as floods, hurricanes, and storms are associated with an increase in drowning, and injuries, psychological disorders, but also contamination of water and food with an increased risk of infectious diseases. Temperature changes affect the interaction of vectors and hosts, changes in ecosystems, and the existence of new species in a certain area, which leads to an increase in diseases transmitted by mosquitoes (malaria, dengue, chikungunya, and West Nile virus), ticks (Lyme disease), flies (leishmaniasis), snails (schistosomiasis), etc. Animal and plant diseases, in addition to natural disasters and pollution, further increase the reduction in the amount of food, which results in an increase in malnutrition of the human population, from which 3.5 million people die every year. Frequent fires (increase in fine particles 2.5-10 mm and dust) and chemical air pollution (increase in the concentration of sulfur oxides, nitrogen oxides, ozone, and fine particles smaller than 2.5 mm) cause an increase in diseases of the respiratory (asthma, bronchitis, pneumonia, lung cancer) and the cardiovascular system (arteriosclerosis, myocardial infarction, deep vein thrombosis, pulmonary embolism). The change in the pattern of plant vegetation, with the increase in the concentration of pollen in the air, leads to an increased incidence of allergic diseases, which will reach the level of a pandemic in 2050 with about four billion people suffering from asthma, allergic rhinitis and atopic dermatitis. Exposure to algae biotoxins in marine animals, water, or air causes short-term memory disorders and worsening of Alzheimer's and Parkinson's diseases, and chemical substances and heavy metals (released from destroyed warehouses in disasters or sewage spills) as well as insecticides and pesticides have immunotoxic, genotoxic and carcinogenic effect. Mental disorders that occur after natural disasters range from acute traumatic stress to chronic stress conditions, such as post-traumatic stress disorders, depression, anxiety, psychosomatic disorders, sexual dysfunctions, and alcohol and drug abuse. The long-term effects of climate change (natural disasters, sea level rise, destruction of the economy, reduction of natural resources of food, water, fuel, risk of local wars) lead to migration, and by 2050 the migration of about 200 million people is expected.

Understanding Differential Response to Biologic Therapies in Severe Asthma: Retrospective study

Severe asthma, characterized by airway inflammation and debilitating symptoms, poses a significant challenge to millions of people worldwide. Traditional treatments for treating severe cases are limited, leading to the emergence of biologic therapies as promising alternatives. This retrospective cohort study from a tertiary hospital in Dubai aimed to explore the differential response to biologics in severe asthma patients and identify predictors of treatment outcomes. The baseline characteristics of 129 severe asthma patients receiving biologic therapy were analyzed, revealing a greater incidence of allergic diseases among responders. Multivariate Cox regression analysis revealed that early-onset asthma, urticaria, and rhinosinusitis (p =0.027, 0.037, and &lt;0.001, respectively) were predictors of a positive treatment response. Compared with non-responders, responders demonstrated improved asthma control, reduced exacerbations, and decreased oral corticosteroid usage. Despite the limitations inherent in retrospective studies, our findings underscore the significant clinical benefits of biologic therapy in severe asthma patients. Tailored treatment strategies based on patient characteristics and biologic class could optimize outcomes in this population, emphasizing the importance of personalized medicine in managing severe asthma. Further research into predictive biomarkers and larger cohort studies are warranted to validate these findings and enhance treatment efficacy in severe asthma management.

Effects of Omega-3 Polyunsaturated Fatty Acid Supplementation on Allergic Diseases in Pregnant Women and Infant

In Westernized nations, there has been a notable rise in the incidence of allergic diseases, which has been associated with a shortage serving of omega-3 polyunsaturated fatty acids (n-3 PUFAs) in diet. Supplementing with fish oil during pregnancy is being considered as a potential method to prevent allergic diseases in offspring. It may also help modulate allergic inflammation in pregnant women by influencing the synthesis of associated inflammatory mediators. The potential biological mechanisms underlying the allergic response in pregnant women and the potential protection provided to offspring through maternal supplementation of n-3 PUFAs are complex but crucial for understanding medical interventions and trial settings. The objective of this paper is to summarize the proposed mechanisms of allergic response and the anti-inflammatory pathways executed by n-3 PUFAs in both pregnant women and their offspring, drawing from important research findings. However, the efficacy of early intervention in infants through neonatal absorption of n-3 PUFAs is still unclear. The results suggest that n-3 PUFAs-induced protection covers a wide range of allergens, including those from food, house dust, and pets, as well as asthma. Conversely, the consumption of fish oil during childhood appears to have an insignificant effect on immunological disorders.

Study of Allergy and Sensitization Relationship in Children and Parents in Southern China

Introduction: The incidence of allergic diseases has increased globally, with genetics playing an essential role in these conditions’ development. However, there is still a gap in understanding of how parental allergy status affects children’s allergies. Methods: An electronic questionnaire was used to assess allergy-related symptoms in kindergarten children and their parents, with a clinical diagnosis and concurrent serum allergen-specific immunoglobulin E (IgE), total IgE, and blood cell counts obtained. Results: 88 family groups were enrolled, with allergy prevalence of 85.2% in children, 50% in fathers, and 42% in mothers. Allergic rhinoconjunctivitis was the most common allergic disease. When the mother had an allergy, the children’s allergy diagnosis rate was 91.3%; 86.67% when the father had an allergy; and 85.71% when both parents had allergies. The child sensitization rate was 78.26% when the father had sensitization, 59.09% just as the mother had sensitization, and 84.21% when both parents had sensitization. Paternal allergies affected children’s quality of life due to allergic rhinitis but not their rhinitis symptoms. Maternal allergies or sensitization did not significantly affect children’s symptoms or quality-of-life scores. Conclusion: The study found a positive correlation between childhood and parental allergies, and further studies are needed to confirm the findings.

Prevalence and Manifestations of Doctor-Diagnosed Allergies in Bulgarian Families with Atopy

Abstract Introduction Food allergy and atopic dermatitis are significant pediatric health problems in many developed countries. The prevalence of these conditions has been increasing over the past two decades in Western societies. However, there is a lack of epidemiological data for Bulgaria. Purpose To study the frequency of different manifestations of doctor-diagnosed allergies among families with atopy in Bulgaria. Materials and methods A cross-sectional study was conducted among 2,408 families with mothers of childbearing age hospitalized between 2017 and 2019 in the Maternity Ward of St. Anna hospital - Varna, Bulgaria. A direct individual questionnaire was applied to obtain information on social-demographic characteristics and manifestations of various forms of allergies. Data was analyzed with SPSS v. 21.0. Results The relative proportion of families with evidence of allergy on the side of the mother, father, or child was 11.63% (n = 280). The incidence of allergic diseases among mothers was 60.5% (n = 127), among fathers 38.6% (n = 8), and among children 57.8% (n = 63). Rhinconjunctivitis was the leading allergic manifestation in mothers (29.5%; n = 62) and fathers (24.8%; n = 52), and atopic dermatitis was the most common manifestation of allergy in their child (30.3%; n = 33). A significant relationship was established between atopic dermatitis in the family and the overall incidence of allergies in the child. Conclusions The data resulting from our study may serve as a basis for further research so the mechanisms of atopy to be investigated better. Prevention strategies need to be developed to address the march of allergy, characterized by the initial manifestation of allergy in childhood with atopic dermatitis and moving to food and respiratory manifestations. Key messages • The incidence of allergies has been increasing in recent years both in the world and in Bulgaria. • Тhe development of preventive measures to reduce the risk of allergic diseases could be of great importance for public health.

Aiming to IgE: Drug development in allergic diseases.

The incidence of allergic disease significantly increases in recent decades, causing it become a major public health problem all over the world. The common allergic diseases such as allergic dermatitis, allergy rhinitis, allergic asthma and food allergy are mediated, at least in part, by immunoglobulin E (IgE), and so IgE acts as a central role in allergic diseases. IgE can interact with its high-affinity receptor (FcεRⅠ) which is primarily expressed on tissue-resident mast cells and circulating basophils, initiating intracellular signal transduction and then causing the activation and degranulation of mast cells and basophils. On the other hand, IgE interaction with its low-affinity receptor (CD23), can regulate various IgE-mediated immune responses including IgE-allergen complex presentation, IgE synthesis, the growth and differentiation of both B and T cells, and the secretion of pro-inflammatory mediators. With the deeper mechanism research for allergic diseases, new therapeutic strategies for interfering IgE are developed and receive a great attention. In this review, we summarize a current profile of therapeutic strategies for interfering IgE in allergic diseases. Besides, we suggest that targeting memory B cells (including long-lived plasma cells and (or) IgE+ memory B cells) may help to completely control allergic diseases, and highlight that the development of drugs synergistically aiming to multiple targets can be a better choice for improving treatment efficacy which results from allergic diseases as the systemic disorders caused by an impaired immune system.

Applications of nanotechnology in allergy and asthma

The increasing incidence of allergic diseases requires effective curative strategies for their alleviation. Allergen-specific immunotherapy (AIT) is a causal treatment technique instead of a symptomatic treatment technique for allergies. At present, AIT is being offered utilizing immunization response modifiers (IRMs) or adjuvants. The adjuvant helps in vigorous inaugral as well as long-term IR (immune response), thus enhancing the efficacy of AIT. The successful development of novel additives requires complete knowledge regarding the underdevelopment of novel and conservative additives. Hence, this review describes the applications of nanotechnology in allergic disorders, namely, allergies and asthma. The development of vaccines based on nanoparticles (NPs) is an important strategy for AIT because of their innate physicochemical characteristics, production ease and capacity to incite inherent immunity.

Effects and potential mechanisms of Saposhnikovia divaricata (Turcz.) Schischk. On type I allergy and pseudoallergic reactions in vitro and in vivo

Ethnopharmacological relevanceThe incidence of allergic disease is constantly increasing, but its pathogenesis is not fully understood. Saposhnikovia divaricata (SD), called ‘Fangfeng’ in China, not only can be used for antipyretic, analgesic and anti-inflammatory as a traditional Chinese medicine, but also as an active ingredient in about 8% prescriptions. However, its effects on type I allergy and pseudoallergy have not been clarified. Aim of the studyTo explore the treatment and potential mechanisms of SD and its major bioactive component Prim-O-glucosylcimifugin (POG) on type I allergy and pseudoallergy in vitro and in vivo. Materials and methodsThe inhibitory effect of SD decoction and POG on type I allergy and its possible mechanism were evaluated by using RBL-2H3 cells model in vitro and the passive cutaneous anaphylaxis (PCA) mouse model in vivo. The cell degranulation of RBL-2H3 cells induced by DNP-IgE/DNP-BSA and Compound 48/80 (C48/80) was investigated, and the molecules of degranulation related signaling pathway was further detected by qRT-PCR and Western Blot analysis. Meanwhile, therapeutic effect of SD Decoction and POG were evaluated using PCA models in vivo. The molecular docking technology was conducted to explore the potential mechanisms. ResultsIn cells model induced by DNP-IgE/DNP-BSA, the release rate of β-Hex in high dose of SD and POG groups were 43.79% and 57.01%, and the release amount of HA in high dose of SD and POG groups were 26.19 ng/mL and 24.20 ng/mL. They were significantly lower than that in the model group. Besides, SD decoction and POG could significantly inhibit intracellular Ca2+ increasing and cell apoptosis. But there is no obvious effect on cells degranulation induced by C48/80. The molecular docking results showed that 5-O-Methylvisamioside and POG could bind with FcεRI α with stronger binding ability, but weak binding ability to Mrgprx2. Moreover, qPCR and Western blot analyses indicated that SD could down-regulate Lyn/Syk/PLCγ, MAPK and PI3K/AKT/NF-κB signal pathway to inhibit IgE-dependent cell degranulation. In mice PCA model, both SD and POG could dose-dependently attenuate the Evans Blue extravasation, paw and ear swelling induced by DNP-IgE/DNP-BSA, but no significant inhibition under the PCA models induced by C48/80. ConclusionIn conclusion, SD is effective for the therapeutic of type I allergies, suggesting that SD is a potential candidate for the treatment of type I allergy, and the underlying mechanism of these effects needs to be further studied.

Infants’ immunisations, their timing and the risk of allergic diseases (INITIAL): an observational prospective cohort study protocol

IntroductionVaccinations are considered to have a large impact on disease control, hence a multitude of vaccines in infancy is recommended. Retrospective studies suggest a possible relation between timing, kind or...

Allergies Come Clean: The Role of Detergents in Epithelial Barrier Dysfunction.

The prevalence and incidence of allergic disease have been rising in Westernized countries since the twentieth century. Increasingly, evidence suggests that damage to the epithelium initiates and shapes innate and adaptive immune responses to external antigens. The objective of this review is to examine the role of detergents as a potential risk factor for developing allergic disease. Herein, we identify key sources of human detergent exposure. We summarize the evidence suggesting a possible role for detergents and related chemicals in initiating epithelial barrier dysfunction and allergic inflammation. We primarily focus on experimental models of atopic dermatitis, asthma, and eosinophilic esophagitis, which show compelling associations between allergic disease and detergent exposure. Mechanistic studies suggest that detergents disrupt epithelial barrier integrity through their effects on tight junction or adhesion molecules and promote inflammation through epithelial alarmin release. Environmental exposures that disrupt or damage the epithelium may account for the increasing rates of allergic disease in genetically susceptible individuals. Detergents and related chemical compounds represent possible modifiable risk factors for the development or exacerbation of atopy.

Early-life interactions between the microbiota and immune system: impact on immune system development and atopic disease.

Prenatal and early postnatal life represent key periods of immune system development. In addition to genetics and host biology, environment has a large and irreversible role in the immune maturation and health of an infant. One key player in this process is the gut microbiota, a diverse community of microorganisms that colonizes the human intestine. The diet, environment and medical interventions experienced by an infant determine the establishment and progression of the intestinal microbiota, which interacts with and trains the developing immune system. Several chronic immune-mediated diseases have been linked to an altered gut microbiota during early infancy. The recent rise in allergic disease incidence has been explained by the 'hygiene hypothesis', which states that societal changes in developed countries have led to reduced early-life microbial exposures, negatively impacting immunity. Although human cohort studies across the globe have established a correlation between early-life microbiota composition and atopy, mechanistic links and specific host-microorganism interactions are still being uncovered. Here, we detail the progression of immune system and microbiota maturation in early life, highlight the mechanistic links between microbes and the immune system, and summarize the role of early-life host-microorganism interactions in allergic disease development.